Accendra Health, Inc.

Accendra Health, Inc.

0.09
USD
-0.05
(-35.08%)
-1.60EPS
43.27MMarket Cap
Feb 24Next Earn

Total Valuation

USD

As of September 30, 2026, Accendra Health, Inc. carries a market capitalization of 43.27M, placing it among publicly traded companies globally. Its enterprise value stands at 1.83B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap43.27M
Enterprise Value1.83B

Important Dates

Accendra Health, Inc.'s next confirmed earnings release is scheduled for February 24, 2027.

Earnings Date2/24/2027

Share Statistics

As of September 30, 2026, Accendra Health, Inc. has 76.90M shares outstanding.

Shares Outstanding76.90M

Valuation Ratios

These figures are as of September 30, 2026. The price-to-sales ratio is 0.02, and the price-to-book ratio stands at -0.08.

PS Ratio0.02
PB Ratio-0.08
P/TBV Ratio-0.02
P/FCF Ratio-0.26
P/OCF Ratio-1.70

Enterprise Valuation

As of September 30, 2026, Accendra Health, Inc. trades at an EV/EBITDA multiple of 9.14 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.72 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 434.37 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 1.83B versus a market cap of 43.27M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales0.72
EV / EBITDA9.14
EV / EBIT434.37

Financial Position

As of September 30, 2026, Accendra Health, Inc. maintains a current ratio of 0.41, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -319.50, indicating conservative leverage, while an interest coverage ratio of 1.51 demonstrates limited ability to service its debt obligations.

Current Ratio0.41
Quick Ratio0.20
Debt / Equity-319.50
Debt / EBITDA9.06
Interest Coverage1.51

Financial Efficiency

USD

These figures cover the twelve months ended September 30, 2026. Return on assets (ROA) is negative at -5.61, reflecting losses generated across the asset base. The company generates approximately 392,577.85 in revenue per employee across its workforce of 6,500.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 19.54 indicates how many times Accendra Health, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Assets (ROA)-5.61
Revenue Per Employee392,577.85
Employee Count6,500.00
Inventory Turnover19.54

Taxes

USD

Over the twelve months ended September 30, 2026, Accendra Health, Inc. recorded an income tax benefit of -25.72M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -148.66M and -171.56M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax-25.72M

Stock Price Statistics

USD

As of the close on November 16, 2026, Accendra Health, Inc.'s stock has declined approximately 96.94% over the past 52 weeks. The 50-day moving average sits at 0.49, while the 200-day moving average is 2.13.

52-Week Price Change-96.94%
50-Day Moving Average0.49
200-Day Moving Average2.13

Income Statement

USD

Over the twelve months ended September 30, 2026, Accendra Health, Inc. generated 2.55B in revenue and converted that into -171.56M in net income, yielding earnings per share of -1.60. EBITDA reached 200.45M, while operating income came in at 106.25M.

Revenue2.55B
Gross Profit1.13B
Operating Income106.25M
Pretax Income-148.66M
Net Income-171.56M
EBITDA200.45M
EBIT4.22M
Earnings Per Share (EPS)-1.60

Balance Sheet

USD

As of September 30, 2026, Accendra Health, Inc. holds 26.61M in cash and equivalents against 1.82B in total debt, resulting in a net debt position of 1.73B. Total book value stands at -568.23M, with working capital of -397.58M providing operational flexibility.

Cash & Cash Equivalents26.61M
Total Debt1.82B
Net Debt1.73B
Equity (Book Value)-568.23M
Book Value Per Share-7.39
Working Capital-397.58M

Cash Flow

USD

Accendra Health, Inc. produced -25.31M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -140.50M in capital expenditures, free cash flow totaled -165.81M - equivalent to -2.16 per share.

Operating Cash Flow-25.31M
Capital Expenditures-140.50M
Free Cash Flow-165.81M
FCF Per Share-2.16

Margins

Over the twelve months ended September 30, 2026, Accendra Health, Inc. posted a gross margin of 44.13, reflecting its pricing power and cost economics. The operating margin of 4.16 and net profit margin of -6.72 provide insight into operational efficiency.

Gross Margin44.13
Operating Margin4.16
Pretax Margin-5.83
Profit Margin-6.72
EBITDA Margin7.86

Dividends & Yields

Over the twelve months ended September 30, 2026, Accendra Health, Inc. paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -384.27: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 711.25, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Accendra Health, Inc. shareholders.

Shareholder Yield711.25
FCF Yield-384.27

Stock Splits

Accendra Health, Inc.'s most recent stock split took place on April 1, 2010 with a 2:3 split ratio.

Last Split Date4/1/2010
Split Ratio2:3

Scores

As of September 30, 2026, Accendra Health, Inc. has an Altman Z-Score of 0.98, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score0.98